≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Thyroiditis, unspecified

DOID EFO Endpoint Browser PheWeb

E4_THYROIDITNAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E06.9
  • Hospital discharge: ICD-9 — 2459
  • Hospital discharge: ICD-8 — 24509
  • Cause of death: ICD-10 — E06.9
  • Cause of death: ICD-9 — 2459
  • Cause of death: ICD-8 — 24509

2 out of 7 registries used, show all original rules.

579

4. Check minimum number of events

None

579

5. Include endpoints

None

579

6. Filter based on genotype QC (FinnGen only)

579

Control definitions (FinnGen only)

Control exclude
E4_THYROID

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E06
Name in latin
Thyreoiditis non specificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4136 3328 780
Only index persons 3597 2934 663
Unadjusted period prevalence (%)
Whole population 0.08 0.10 0.02
Only index persons 0.09 0.11 0.03
Median age at first event (years)
Whole population 43.92 43.41 45.87
Only index persons 42.03 41.65 43.74

-FinnGen-

Key figures

All Female Male
Number of individuals 579 481 98
Unadjusted period prevalence (%) 0.14 0.16 0.04
Median age at first event (years) 40.68 40.11 43.50

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
528
Matched controls
5279
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E06.9
ICD-10 Finland
Thyroiditis, unspecified
9715.9
323.0
371
*
H03AA01
ATC
levothyroxine sodium; systemic
88.2
264.0
287
70
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
208.7
150.5
150
10
104
Kela drug reimbursment
Thyroid insufficiency
336.8
131.6
128
5
24509
ICD-8 Finland
Thyroiditis, Unspecified
+∞
110.4
102
*
H03BB01
ATC
carbimazole; oral
235.1
79.7
80
*
E06.1
ICD-10 Finland
Subacute thyroiditis
+∞
68.2
64
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
685.6
63.2
61
*
2459X
ICD-9 Finland
Thyroiditis, unspecified
+∞
57.3
54
*
E03
ICD-10 Finland
Other hypothyroidism
68.0
48.3
55
9
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
452.3
42.8
42
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
440.5
41.7
41
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
210.1
38.3
39
*
T86
ICPC
Hypothyroidism/myxoedema
67.9
28.3
32
5
E06.3
ICD-10 Finland
Autoimmune thyroiditis
76.4
26.0
29
*
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
36.5
24.5
31
9
BAA60
NOMESCO Finland
Total thyroidectomy
131.0
23.8
25
*
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
+∞
22.0
21
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
24.8
18.8
26
11
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
40.0
18.7
23
6
C07AA05
ATC
propranolol; systemic
2.8
18.5
139
597
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
98.4
17.7
19
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.3
17.1
53
108
E06.0
ICD-10 Finland
Acute thyroiditis
+∞
16.8
16
*
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
23.0
14.3
20
9
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
14.1
216
1299
H02AB06
ATC
prednisolone; systemic
2.1
14.1
263
1718
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
71.6
12.6
14
*
A02BC02
ATC
pantoprazole; systemic
1.9
11.0
341
2592
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
112.2
10.5
11
*
E06
ICD-10 Finland
Thyroiditis
112.2
10.5
11
*
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
10.2
141
794
H02AB07
ATC
prednisone; oral
2.4
10.2
95
449
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
101.8
9.4
10
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
9.0
69
293
N03AX16
ATC
pregabalin; oral
2.0
8.5
129
746
R53
ICD-10 Finland
Malaise and fatigue
2.1
8.4
104
554
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
+∞
8.4
8
*
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
+∞
8.4
8
*
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
+∞
8.4
8
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
9.7
8.3
16
17
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
8.2
98
515
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.1
8.1
94
486
R06.0
ICD-10 Finland
Dyspnoea
1.9
7.9
126
742
N02AX02
ATC
tramadol; systemic, rectal
1.7
7.7
206
1434
J01DB01
ATC
cefalexin; oral
1.8
7.6
426
3663
C07AB07
ATC
bisoprolol; oral
1.7
7.5
211
1483
E05.89
ICD-10 Finland
Other thyrotoxicosis
81.2
7.4
8
*
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
+∞
7.3
7
*
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
+∞
7.3
7
*
M54.5
ICD-10 Finland
Low back pain
1.7
7.2
175
1178
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
7.2
93
502
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
30.5
7.2
9
*
T85
ICPC
Hyperthyroidism/thyrotoxicosis
30.5
7.2
9
*
A02BC03
ATC
lansoprazole; oral
1.8
7.1
152
983
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
7.0
90
484
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.2
7.0
25
62
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.6
6.8
22
49
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
6.8
171
1157
UJF32
NOMESCO Finland
Coloscopy
1.8
6.6
124
768
A02BC05
ATC
esomeprazole; systemic
1.6
6.5
210
1520
M79.6
ICD-10 Finland
Pain in limb
1.7
6.5
181
1260
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
70.7
6.4
7
*
J01DA01
ATC
[U] cefalexin; systemic
1.6
6.3
329
2683
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
6.3
106
632
E06.5
ICD-10 Finland
Other chronic thyroiditis
+∞
6.3
6
*
2504
FHL
Unilateral resection or enucleation
+∞
6.3
6
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
6.3
127
804
G44.2
ICD-10 Finland
Tension-type headache
2.0
6.2
79
426
UKC02
NOMESCO Finland
Cystoscopy
2.2
6.2
64
314
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
4.0
6.2
23
60
N03AX12
ATC
gabapentin; oral
2.0
6.2
80
433
A04
ICPC
Weakness/tiredness general
2.1
6.2
70
358
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
12.7
6.1
10
8

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
148
145
13.37
138.81
4.0
1.5
pmol/l
4.4
4.4
0.01
132
127
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
92
66
16.38
102.90
2.4
1.2
iu/l
2.2
2.2
0.01
32
13
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
135
270
6.22
67.45
1.6
1.1
iu/ml
258.9
79.4
4.12
65
80
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
514
3616
4.75
35.69
8.7
2.6
pmol/l
15.3
14.3
13.25
486
3300
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
529
4408
3.32
16.05
10.1
3.4
mu/l
1.8
1.8
0.01
496
4060
(3013650) Neutrophils [#/volume] in Blood by Automated count
365
2709
1.94
12.93
9.4
8.5
e9/l
4.2
4.1
0.36
328
2352
(3002030) Lymphocytes/100 leukocytes in Blood
319
2267
1.91
12.88
6.6
5.3
%
28.8
28.5
0.15
290
2107
(3013826) Glucose [Moles/volume] in Serum or Plasma
348
2549
1.92
12.75
4.9
4.1
mmol/l
6.7
6.5
0.67
330
2353
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
282
1934
1.89
12.62
2.6
2.2
nmol/l
78.6
77.2
0.36
252
1754
(3019198) Lymphocytes [#/volume] in Blood
329
2390
1.87
12.11
6.3
5.2
e9/l
2.0
1.9
0.54
300
2109
(42870588) Differential panel, method unspecified - Blood
231
1502
1.90
12.05
6.6
5.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
304
2159
1.86
11.98
3.5
2.6
ug/l
110.0
90.4
1.12
275
1998
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
276
1908
1.85
11.80
6.1
4.8
mmol/l
1.2
1.2
0.65
251
1734
(3022096) Basophils/100 leukocytes in Blood
298
2117
1.84
11.60
6.4
5.3
%
0.7
0.7
0.27
273
1959
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
440
3539
2.01
11.60
7.8
6.6
u/l
78.8
76.3
0.26
417
3321
(3013115) Eosinophils [#/volume] in Blood
329
2410
1.85
11.59
7.0
5.6
e9/l
0.2
0.2
0.65
299
2120
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
175
1050
1.96
11.54
2.4
2.1
mg/l
2.8
3.0
0.36
150
895
(3018010) Neutrophils/100 leukocytes in Blood
311
2243
1.84
11.48
6.4
5.1
%
56.2
57.1
0.64
287
2097
(3001604) Monocytes [#/volume] in Blood
317
2315
1.82
11.09
6.4
5.2
e9/l
0.6
0.6
0.88
277
2004
(3019069) Monocytes/100 leukocytes in Blood
305
2203
1.81
11.05
7.0
5.4
%
8.4
8.2
0.25
283
2057
(3013707) Erythrocyte sedimentation rate by Westergren method
434
3504
1.95
10.90
5.4
3.9
mm/h
13.1
11.3
1.66
407
3240
(3006504) Eosinophils/100 leukocytes in Blood
303
2197
1.80
10.73
6.6
5.2
%
2.9
2.7
0.56
280
2035
(3006315) Basophils [#/volume] in Blood
317
2330
1.80
10.71
6.4
5.2
e9/l
0.0
0.0
0.32
279
2013
(3037522) Nuclear Ab [Titer] in Serum
121
661
2.05
10.28
1.6
1.3
titre
722.2
466.8
0.54
36
136
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
292
2120
1.76
10.07
6.9
5.6
mmol/l
1.2
1.2
0.03
246
1794
(3032080) INR in Blood by Coagulation assay
239
1640
1.78
10.00
9.8
7.7
inr
1.2
1.2
0.68
64
484
(3022948) Iron [Moles/volume] in Serum or Plasma
114
617
2.06
9.90
2.6
2.1
umol/l
12.8
13.4
0.38
101
562
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
241
1691
1.73
9.11
2.1
1.9
pmol/l
97.6
94.5
0.39
123
851
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
310
2351
1.69
8.63
5.5
5.4
umol/l
9.6
10.6
1.02
292
2221
(3036481) Cortisol [Moles/volume] in Serum or Plasma
76
370
2.21
8.63
2.3
1.8
nmol/l
368.3
374.5
0.10
65
339
(3007164) IgA [Mass/volume] in Serum or Plasma
154
966
1.81
8.48
1.6
1.4
g/l
2.1
2.3
0.80
84
581
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
226
1582
1.70
8.47
4.7
3.2
ng/l
28.8
28.7
0.00
139
971
(3015377) Calcium [Moles/volume] in Serum or Plasma
215
1488
1.71
8.38
2.4
3.3
mmol/l
2.3
2.4
1.54
173
1319
(40768797) Stomach Pathology biopsy report
112
637
1.94
8.37
1.2
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
384
3105
1.70
8.20
5.7
4.2
e6/l
4429.6
4513.5
—
7
42
(3004789) Transferrin [Mass/volume] in Serum or Plasma
102
568
1.97
8.09
2.5
2.1
g/l
2.4
2.4
0.13
88
522
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
164
1062
1.76
8.06
3.4
2.7
ng/l
2203.4
973.7
1.62
136
897
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
166
1083
1.75
7.93
2.2
1.7
mg/l
0.9
1.0
0.52
123
809
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
43
169
2.67
7.78
1.8
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
169
1115
1.73
7.73
1.4
1.2
u/ml
0.8
2.0
1.44
35
283
(3024980) IgG subclass 4 [Mass/volume] in Serum
23
62
3.82
7.70
1.7
2.1
g/l
0.9
1.0
0.08
23
53
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
188
1280
1.69
7.65
2.4
2.0
u/l
142.5
169.8
0.40
179
1219
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
30
99
3.14
7.42
1.3
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
393
3249
1.65
7.20
5.5
4.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
93
524
1.92
7.09
1.6
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
532
4833
2.24
6.78
19.2
12.9
mmol/l
3.9
3.9
0.25
525
4676
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
92
524
1.90
6.78
2.7
2.2
%
21.0
22.5
0.41
69
453
(3019550) Sodium [Moles/volume] in Serum or Plasma
531
4823
2.22
6.73
19.3
12.9
mmol/l
139.5
139.7
1.21
525
4684
(3023368) Bacteria identified in Blood by Culture
157
1060
1.66
6.43
4.9
3.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
113
704
1.75
6.20
1.9
1.7
nmol/l
1174.0
1195.8
0.08
95
530
(3027945) Reticulocytes/100 erythrocytes in Blood
75
413
1.94
6.10
2.0
2.5
%
1.7
1.7
0.02
65
365
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
526
4792
2.07
6.10
18.9
11.7
mg/l
20.5
22.1
0.60
438
3699
(3021879) Hepatitis B virus core Ab [Presence] in Serum
65
342
2.01
6.02
1.6
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
205
1503
1.56
5.89
3.3
3.0
u/l
30.2
30.5
0.08
197
1439
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
36
4.25
5.85
2.3
3.7
—
—
—
0
0
(3019225) pH of Specimen
71
390
1.94
5.82
5.4
3.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
81
465
1.86
5.81
23.1
19.4
inr
1.2
1.2
0.05
14
62
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
189
1369
1.56
5.70
3.0
2.2
u/l
56.4
55.4
0.11
176
1259
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
58
300
2.04
5.63
3.0
2.8
ng/l
147.3
155.2
0.07
53
275
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
131
871
1.65
5.62
1.4
1.3
u/ml
7.6
9.8
0.22
62
343
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
28
105
2.75
5.58
2.8
2.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
156
1087
1.60
5.53
2.1
2.3
umol/l
328.6
6575.0
4.67
132
959
(3044889) 12 lead EKG panel
376
3174
1.53
5.44
4.0
3.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
136
921
1.62
5.41
1.4
1.3
iu/ml
21.5
31.2
1.07
49
287
(3024561) Albumin [Mass/volume] in Serum or Plasma
238
1829
1.51
5.41
4.1
4.0
g/l
35.3
36.0
1.17
220
1705
(3018418) pH of Serum or Plasma
177
1276
1.56
5.40
3.9
3.1
ph
7.4
7.4
0.21
30
242
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
137
2.49
5.39
1.7
1.5
iu/ml
0.0
0.1
—
9
29
(3007853) Bacteria identified in Skin by Aerobe culture
84
500
1.80
5.36
2.1
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
122
807
1.65
5.32
4.8
3.4
ng/l
61.0
323.2
2.24
82
579
(3019150) Specific gravity of Urine by Refractometry
144
994
1.60
5.28
4.4
3.8
kg/l
1.0
1.0
1.18
28
135
(3001019) Free T4 and TSH panel - Serum or Plasma
54
283
2.00
5.07
2.9
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
194
1446
1.51
5.02
3.4
2.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
208
1582
1.49
4.85
3.9
3.3
e6/l
42.3
77.4
1.02
151
1056
(3023520) Reticulocytes [#/volume] in Blood
55
295
1.96
4.84
1.9
2.8
e9/l
69.7
71.7
0.15
44
206
(40760892) CBC W Ordered Manual Differential panel - Blood
150
1073
1.54
4.65
3.5
4.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
163
1191
1.51
4.57
7.4
6.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
21
4.83
4.54
3.0
4.4
u/ml
885.6
649.2
—
10
21
(3012095) Magnesium [Moles/volume] in Serum or Plasma
100
654
1.64
4.53
3.3
2.8
mmol/l
0.8
0.8
1.83
94
620
(3048689) Calprotectin [Mass/mass] in Stool
91
585
1.66
4.40
2.0
2.2
ug/g
179.4
98.6
0.54
66
448
(36660697) Celiac disease serology panel - Serum
68
404
1.77
4.37
1.2
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
159
1167
1.50
4.34
3.1
2.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
127
889
1.55
4.32
2.6
2.4
e6/l
9.3
7.5
0.22
110
773
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
70
421
1.75
4.31
2.3
2.1
u/l
29.0
32.9
0.65
57
349
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
540
5062
1.99
4.29
12.1
9.2
u/l
24.8
24.4
0.31
524
4893
(3035350) Ketones [Presence] in Urine by Test strip
284
2334
1.43
4.25
4.1
3.4
estimate
0.0
0.0
0.00
47
429
(3002582) Erythrocytes [#/volume] in Urine
174
1309
1.47
4.18
3.3
2.8
e6/l
50.7
123.2
0.64
136
973
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
52
290
1.87
4.10
1.4
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
34
163
2.15
4.06
1.5
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
287
2376
1.41
4.06
4.3
3.5
estimate
0.0
0.0
0.80
47
418
(3020779) Urea [Moles/volume] in Serum or Plasma
54
306
1.84
4.05
7.1
5.7
mmol/l
10.9
8.4
1.56
54
292
(3017704) Immunofixation for Urine
9
14
6.51
3.99
1.4
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
485
4438
1.57
3.92
14.7
10.9
ml/min/173m2
83.3
83.9
0.25
410
3569
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
496
4563
1.61
3.91
4.8
4.1
mmol/l
5.9
5.8
0.50
452
4192
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
114
797
1.54
3.87
1.7
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
154
1147
1.47
3.85
4.4
3.4
%
96.9
95.3
0.35
149
1118
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
99
674
1.57
3.78
2.0
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
282
2347
1.39
3.77
5.8
4.7
estimate
0.0
0.0
0.50
47
426
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
40
3.30
3.64
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
40
3.30
3.64
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
40
3.30
3.64
1.2
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
362
3152
1.40
3.64
3.4
2.9
u/l
43.3
42.0
0.14
343
2962
(3017732) Neutrophils [#/volume] in Blood
54
317
1.78
3.63
2.8
2.5
e9/l
4.6
3.9
0.69
36
255
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
44
243
1.88
3.59
1.5
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
32
158
2.09
3.57
2.1
1.9
g/l
1.8
1.5
0.64
26
138
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
28
131
2.20
3.57
1.3
1.2
u/ml
5.3
3.3
—
6
16
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
41
3.22
3.51
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
41
3.22
3.51
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
41
3.22
3.51
1.2
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
68
431
1.65
3.48
2.7
4.0
u/l
240.4
238.1
0.06
63
406
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
28
133
2.16
3.45
1.3
1.2
u/ml
9.8
6.7
—
6
26
(3020682) Albumin/Creatinine [Ratio] in Urine
156
1189
1.43
3.41
3.7
3.9
mg/mmol
11.6
10.2
0.11
102
744
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
95
2.37
3.38
1.4
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
12
37
3.29
3.36
1.7
1.2
g/l
6.7
7.5
0.30
12
29
(3024139) IgG subclass 3 [Mass/volume] in Serum
12
37
3.29
3.36
1.7
1.2
g/l
0.3
0.3
0.19
12
29
(3028192) IgG subclass 2 [Mass/volume] in Serum
12
37
3.29
3.36
1.7
1.2
g/l
2.9
2.7
0.24
12
28
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
130
966
1.45
3.25
1.9
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
466
4275
1.46
3.25
6.1
5.0
mmol/mol
40.0
38.9
1.35
421
4001
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
55
2.77
3.17
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
149
1140
1.41
3.17
3.1
3.2
mg/l
44.7
342.6
1.68
94
734
(3048929) Epstein Barr virus Ab [Presence] in Serum
28
138
2.08
3.16
1.5
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
120
883
1.45
3.15
1.7
1.6
pmol/l
422.5
42530714.5
1.58
94
743
(3030467) Casts [#/volume] in Urine by Automated count
154
1188
1.40
3.12
3.2
2.8
e6/l
0.2
0.5
2.21
118
864
(3009542) Hematocrit [Volume Fraction] of Blood
483
4474
1.48
3.08
19.5
12.8
%
39.1
39.4
0.37
351
3375
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
38
211
1.86
3.08
3.8
3.7
mmol/l
3.5
1.8
1.06
31
155
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
56
2.72
3.08
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
56
2.72
3.08
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
376
3346
1.35
2.99
3.7
3.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
57
2.67
2.98
1.1
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
57
2.67
2.98
1.2
1.2
—
—
—
0
0
(3013512) EKG study
153
1188
1.39
2.97
4.1
3.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
163
1.95
2.96
2.4
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
130
982
1.42
2.96
1.7
1.5
nmol/l
17.5
22.4
3.68
103
832
(3025941) Bacteria identified in Stool by Culture
46
276
1.72
2.90
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
30
157
1.96
2.90
4.1
3.8
—
—
—
0
0
(4015189)
6
9
6.72
2.87
2.0
4.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
239
2000
1.33
2.85
2.1
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
71
2.44
2.82
1.8
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
164
1299
1.37
2.80
3.6
3.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
501
4697
1.49
2.78
4.7
4.0
mmol/l
4.7
4.8
1.08
461
4394
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
499
4676
1.49
2.76
4.7
3.9
mmol/l
1.5
1.6
2.30
453
4355
(46235355) HIV 1 and 2 tests - Meaningful Use set
126
958
1.40
2.75
1.9
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
157
1239
1.37
2.74
2.9
3.0
mmol/l
6.9
7.2
0.28
132
1060
(3026782) Osmolality of Urine
112
835
1.42
2.73
2.3
2.5
mosm/kgh2o
489.5
533.3
1.31
91
705
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
218
1810
1.33
2.71
4.3
3.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
28
148
1.94
2.65
1.6
1.9
ug/l
0.9
2.9
0.51
23
136
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
149
1.92
2.60
2.3
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
19
87
2.22
2.60
1.0
1.1
u/ml
5.0
5.2
—
8
43
(4035726)
58
382
1.58
2.58
1.4
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
20
4.04
2.57
1.1
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
20
4.04
2.57
1.1
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
139
1087
1.37
2.55
2.8
2.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
11
5.50
2.55
1.2
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
11
5.50
2.55
1.2
1.1
%
101.2
101.7
—
6
11
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
56
2.54
2.55
1.1
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
17
75
2.30
2.53
1.6
1.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
90
654
1.45
2.52
3.0
2.6
e6/l
4.4
3.3
0.30
47
322
(3024928) Oxygen saturation in Venous blood
18
82
2.23
2.50
3.2
2.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
57
2.49
2.46
1.1
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
50
322
1.61
2.45
2.0
2.5
g/l
66.1
67.7
0.76
43
297
(3000494) Fungus identified in Specimen by Culture
75
529
1.48
2.45
1.7
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
83
2.21
2.43
1.0
1.1
u/ml
0.2
0.9
—
8
34
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
31
175
1.82
2.43
1.7
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
528
5031
1.56
2.42
17.4
11.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
68
472
1.50
2.40
1.7
1.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
23
118
1.99
2.38
1.2
1.2
—
386.0
—
0
5
(3044927) Protein electrophoresis panel - Urine
11
40
2.78
2.38
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
36
214
1.73
2.38
1.7
1.8
mg/l
3.1
2.9
0.09
25
152
(3026361) Erythrocytes [#/volume] in Blood
556
5371
1.89
2.37
27.6
17.4
e12/l
4.4
4.4
0.45
547
5219
(3002256) Pathology report gross observation
83
602
1.44
2.35
1.2
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
556
5373
1.88
2.34
27.8
17.5
e9/l
6.7
6.6
0.57
547
5219
(3044640) Blood type and Crossmatch panel - Blood
175
1436
1.31
2.31
2.9
2.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
14
59
2.41
2.31
1.4
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
24
127
1.93
2.29
3.2
3.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
41
2.72
2.29
1.6
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
50
328
1.57
2.28
3.9
4.1
%
0.6
0.6
0.04
12
72
(3007461) Platelets [#/volume] in Blood
555
5365
1.83
2.26
27.7
17.5
e9/l
263.5
258.3
1.04
546
5231
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
157
1.82
2.25
1.3
1.6
g/l
9.9
10.6
0.42
23
140
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
254
2196
1.28
2.23
4.4
3.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
66
463
1.48
2.22
5.6
5.9
mmol/l
104.0
104.4
0.28
66
455
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
48
315
1.57
2.19
2.1
2.2
ug/l
3.4
5.6
1.83
38
278
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
74
2.20
2.16
1.3
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
167
1.78
2.15
1.2
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
167
1.78
2.15
1.2
1.6
g/l
3.6
3.8
0.37
20
126
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
167
1.78
2.15
1.3
1.6
g/l
7.3
7.5
0.19
21
135
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
93
701
1.39
2.13
3.0
2.4
e6/l
1.1
1.2
0.28
51
369
(4062490)
10
37
2.73
2.11
1.7
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
69
494
1.45
2.11
1.3
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
102
784
1.37
2.08
2.2
2.7
mmol/l
2.4
2.5
1.78
90
693
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
24
132
1.85
2.07
1.7
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
503
4775
1.41
2.06
5.2
4.4
mmol/l
2.8
2.8
1.12
460
4439
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
477
4491
1.35
2.05
4.2
3.6
mmol/l
1.3
1.2
1.27
435
4161
(3017181) Myelocytes/100 leukocytes in Blood
53
362
1.51
2.04
3.9
4.0
%
0.8
1.0
0.35
14
104
(3021589) Normoblasts [#/volume] in Blood
239
2070
1.26
2.02
10.3
8.5
e9/l
0.0
0.0
0.95
197
1687
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
36
225
1.64
2.02
2.9
2.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
54
372
1.50
2.00
7.0
7.2
%
94.3
95.9
0.60
54
360
(3000991) Gas panel - Venous blood
46
306
1.55
2.00
6.3
7.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
24
135
1.81
1.94
1.3
1.6
g/l
39.9
38.0
0.67
19
120
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
33
2.75
1.94
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
19
99
1.95
1.92
1.2
1.1
u/ml
1.0
1.8
—
7
33
(3019060) Gas panel - Arterial blood
38
245
1.59
1.89
6.3
4.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
45
302
1.53
1.89
3.1
2.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
66
479
1.43
1.89
1.8
1.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
22
3.21
1.88
1.3
1.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
25
144
1.77
1.88
1.3
1.8
g/l
0.0
1.0
1.82
20
131
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
69
508
1.41
1.83
6.8
6.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
42
281
1.53
1.80
1.8
2.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
68
501
1.40
1.80
2.7
2.6
umol/l
5.7
6.4
0.28
55
422
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70
519
1.40
1.79
4.5
4.0
%
33.3
32.6
0.18
51
349
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
36
2.52
1.74
1.3
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
8
30
2.69
1.73
1.1
1.9
nmol/l
22.5
21.5
—
8
30
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
82
1.98
1.71
1.1
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
157
1.69
1.68
1.3
1.6
g/l
3.2
3.1
0.15
20
130
(3051593) INR in Capillary blood by Coagulation assay
5
14
3.59
1.62
6.6
18.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
14
3.59
1.62
1.8
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
14
3.59
1.62
1.2
1.3
iu/ml
88.7
213.1
—
5
14
(3025159) Blasts/100 leukocytes in Blood
46
322
1.47
1.61
4.0
4.3
%
0.0
0.2
0.86
14
77
(3021447) Carbon dioxide [Partial pressure] in Venous blood
50
356
1.44
1.61
4.7
3.1
kpa
6.0
5.8
0.85
50
346
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
20
3.02
1.58
1.7
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
20
3.02
1.58
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
20
3.02
1.58
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
20
3.02
1.58
1.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
20
3.02
1.58
1.7
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
49
352
1.43
1.51
7.4
7.4
g/l
120.3
119.7
0.09
49
341
(3029937) Albumin [Presence] in Urine by Test strip
147
1241
1.25
1.50
4.7
3.7
estimate
0.0
0.0
0.80
46
421
(3008898) HLA-B27 [Presence]
32
212
1.54
1.46
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
102
1.79
1.46
1.7
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
38
2.39
1.46
2.0
2.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
28
2.52
1.45
2.6
3.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
28
2.52
1.45
1.3
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
16
3.14
1.44
4.6
2.2
—
—
—
0
0
(3012544) pH of Venous blood
50
365
1.40
1.42
5.1
3.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
30
198
1.54
1.40
2.0
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
67
1.96
1.39
1.5
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
23
2.62
1.37
1.2
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
58
439
1.36
1.34
6.7
6.7
mmol/l
1.9
1.3
0.84
49
344
(3043409) Potassium [Moles/volume] in Arterial blood
18
105
1.74
1.34
7.4
4.7
mmol/l
3.7
3.9
0.62
18
99
(4268621)
11
54
2.06
1.33
2.5
2.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
47
344
1.40
1.33
4.0
4.1
%
0.0
0.2
3.33
14
94
(3019230) Fractional oxyhemoglobin in Venous blood
12
62
1.96
1.28
2.8
1.6
%
60.6
63.1
0.16
12
62
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
229
1.47
1.25
2.5
2.0
u/l
1516.1
2842.1
0.54
17
95
(4024509)
8
36
2.24
1.24
2.1
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
45
2.02
1.23
1.4
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
19
2.65
1.22
5.0
3.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
37
2.18
1.22
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
71
1.85
1.20
1.7
2.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
86
1.76
1.20
1.7
1.2
u/ml
5.0
3.1
—
7
32
(4146454)
6
26
2.32
1.19
2.2
2.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
38
2.12
1.19
1.1
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
27
182
1.51
1.18
2.5
2.1
%
0.7
0.7
0.11
27
175
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
79
1.79
1.18
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
79
1.79
1.18
1.3
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
127
1086
1.22
1.14
4.5
3.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
96
1.69
1.11
4.6
3.6
mg/l
21.3
30.0
—
8
59
(3035320) C reactive protein [Mass/volume] in Body fluid
7
31
2.27
1.10
2.9
2.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
31
2.27
1.10
1.4
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
143
1242
1.20
1.10
1.8
1.6
mmol/l
1.4
1.4
0.43
116
1062
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
66
1.84
1.09
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
41
1.96
1.09
1.5
2.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
254
1.40
1.07
1.3
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
19
122
1.58
1.03
6.6
5.7
mmol/l
1.2
1.2
0.08
19
107
(1616796) Gas panel - Central venous blood
13
75
1.75
1.03
2.8
3.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
68
550
1.27
1.02
1.7
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
33
240
1.40
1.01
3.5
2.7
g/l
132.3
127.5
0.56
33
234
(3014051) Protein [Presence] in Urine by Test strip
16
99
1.63
1.01
2.1
2.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
48
1.89
1.01
3.8
3.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
35
2.01
1.00
1.3
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
45
346
1.33
0.98
3.3
3.2
mmol/l
1.2
1.2
1.58
36
308
(4211845)
5
23
2.18
0.98
5.0
3.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
92
1.65
0.98
1.7
1.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
19
124
1.55
0.98
1.4
3.1
—
2.6
—
0
12
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
30
0.00
0.97
0.0
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
50
1.81
0.97
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
43
330
1.33
0.96
1.4
1.2
—
—
—
0
0
(4010399)
43
331
1.32
0.94
1.5
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
27
2.23
0.93
2.3
2.1
—
—
—
0
0
(3020891) Body temperature
21
142
1.50
0.93
6.7
4.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
52
1.74
0.92
1.3
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
6
28
2.15
0.91
2.3
2.1
%
13.3
11.0
—
6
16
(40761536) Microorganisms panel - Urine sediment
50
395
1.29
0.91
3.4
3.7
—
—
—
0
0
(3039000) Anion gap in Blood
14
86
1.64
0.91
6.4
6.1
mmol/l
10.6
10.9
0.15
14
77
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
86
1.64
0.91
1.6
1.2
u/ml
1.4
4.4
—
5
26
(3034274) Bile acid [Moles/volume] in Serum --fasting
14
86
1.64
0.91
2.2
2.7
umol/l
4.7
6.5
—
9
61
(3018572) Chloride [Moles/volume] in Blood
14
86
1.64
0.91
6.4
6.2
mmol/l
104.9
105.5
0.24
14
77
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
45
351
1.31
0.90
2.1
2.4
ml/min/173m2
68.8
71.0
0.11
19
132
(3011648) Oxygen content in Venous blood
6
29
2.08
0.89
1.7
1.6
%
12.6
12.2
—
6
29
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
203
1.40
0.89
7.6
7.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
42
1.92
0.89
2.8
3.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
45
353
1.30
0.87
4.1
3.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
6
30
2.01
0.87
3.8
2.3
—
798.7
—
0
10
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
153
1.46
0.87
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
44
1.83
0.86
1.3
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
112
1.53
0.85
1.4
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
130
1.48
0.82
1.3
1.2
—
—
—
0
0
(4094501)
16
106
1.52
0.79
1.3
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
25
182
1.39
0.79
1.2
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
66
1.68
0.79
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
74
1.63
0.78
1.2
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
13
82
1.60
0.78
1.5
1.7
—
—
—
0
0
(44790048)
9
53
1.71
0.75
1.3
1.4
—
—
—
0
0
(44806118)
9
53
1.71
0.75
1.3
1.4
—
—
—
0
0
(44790047)
9
53
1.71
0.75
1.3
1.4
—
—
—
0
0
(44790049)
9
53
1.71
0.75
1.3
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
54
1.68
0.75
4.8
2.5
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
5
24
2.09
0.74
1.4
2.2
mmol/l
5.9
6.8
—
5
16
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
43
345
1.27
0.73
1.6
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
14
92
1.53
0.73
1.5
3.6
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
7
39
1.80
0.72
1.3
1.2
nmol/l
392.4
389.1
—
7
33
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
56
1.62
0.72
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
69
584
1.21
0.72
5.4
4.7
ug/l
6.4
2.7
0.43
63
522
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
84
1.56
0.72
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
21
151
1.41
0.72
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
19
135
1.42
0.70
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
77
1.57
0.69
1.5
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
27
1.86
0.68
1.4
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
5
27
1.86
0.68
1.4
2.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
42
1.67
0.68
1.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
44
537
0.80
0.68
1.4
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
48
394
1.24
0.68
2.0
1.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
94
1.50
0.67
2.3
2.2
g/l
137.5
130.5
—
8
66
(3037121) Protein [Mass/volume] in Urine
20
145
1.39
0.66
2.1
3.2
g/l
0.6
0.2
—
10
58
(3042936) Bacteria identified in Isolate by Culture
71
610
1.19
0.65
2.6
1.8
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
29
1.73
0.64
2.0
1.3
ug/l
4.3
5.5
—
5
23
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
63
537
1.19
0.63
1.5
1.7
%
1.4
1.4
0.05
55
478
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
17
121
1.42
0.63
1.4
1.5
mg/l
546.4
480.4
0.25
17
114
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
50
1.61
0.61
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
13
88
1.49
0.61
2.3
1.7
e6/l
5926.4
13501.6
—
8
62
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
51
1.58
0.60
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
150
0.66
0.59
1.4
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
25
195
1.29
0.55
1.3
1.3
miu/ml
145.4
248.6
0.86
14
101
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
52
442
1.19
0.55
3.5
3.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
82
1.47
0.54
1.7
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
74
1.50
0.53
1.4
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
66
1.52
0.53
5.0
2.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
16
117
1.38
0.52
3.0
2.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
39
324
1.22
0.52
1.2
1.4
iu/l
31.3
30.5
0.04
30
281
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
92
1.42
0.51
1.5
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
22
171
1.30
0.50
1.6
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
52
448
1.18
0.49
2.2
3.9
ug/l
2.6
18.7
0.99
37
357
(1761868) Lipid panel - Serum or Plasma
189
1771
1.10
0.48
2.8
2.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
17
222
0.76
0.48
1.2
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
65
572
1.15
0.47
1.7
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
48
1.46
0.47
2.6
2.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
118
0.67
0.46
3.4
4.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
283
1.21
0.46
1.0
1.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
11
77
1.44
0.46
2.9
1.5
ug/l
11.5
2.7
0.39
11
68
(42529406) Shigella sp [Presence] in Stool by Culture
20
156
1.29
0.45
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
104
1.35
0.43
1.2
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
31
1.62
0.43
1.2
1.7
promille
0.2
1.1
—
5
22
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
32
1.57
0.42
1.2
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
33
1.52
0.41
2.2
1.5
g/l
1.1
1.0
—
5
33
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.0
—
126.7
—
0
9
(3044242) Glucose [Moles/volume] in Arterial blood
0
16
0.00
0.41
0.0
7.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
34
1.47
0.40
1.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
18
0.00
0.40
0.0
6.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.0
1.8
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
36
1.39
0.38
1.2
1.1
mg/l
27.2
30.4
—
5
30
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
36
1.39
0.38
1.2
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
89
1.36
0.38
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
89
1.36
0.38
1.3
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
28
234
1.21
0.38
1.4
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
71
1.27
0.36
3.1
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
134
0.74
0.35
2.5
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
43
1.40
0.35
1.3
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
53
473
1.13
0.34
1.7
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
45
1.34
0.34
1.5
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
20
164
1.23
0.33
2.0
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
74
1.36
0.32
2.0
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
16
128
1.26
0.32
5.3
2.5
g/l
3.7
3.7
0.04
16
122
(3027008) Opiates [Presence] in Urine
20
166
1.21
0.30
2.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
166
1.21
0.30
2.0
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
55
1.28
0.30
2.1
2.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
19
157
1.22
0.30
6.8
4.9
%
1.2
0.9
1.08
19
146
(3035285) Chloride [Moles/volume] in Venous blood
7
56
1.25
0.29
2.1
2.3
mmol/l
104.4
106.1
—
7
56
(3041354) Potassium [Moles/volume] in Venous blood
7
56
1.25
0.29
2.1
2.3
mmol/l
4.3
4.0
—
7
56
(3023419) Bacteria identified in Sputum by Culture
7
56
1.25
0.29
1.6
2.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
63
1.27
0.28
1.9
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
60
548
1.11
0.28
1.6
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
168
1.20
0.27
2.1
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
29
253
1.15
0.26
1.5
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
69
637
1.09
0.26
2.1
2.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
77
1.30
0.26
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
72
0.69
0.26
2.8
1.7
—
—
—
0
0
(4306422)
9
73
1.24
0.25
1.4
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
73
1.24
0.25
1.7
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
74
1.22
0.25
1.6
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
74
1.22
0.25
1.4
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
9
74
1.22
0.25
2.2
3.3
umol/l
27.4
34.6
—
9
62
(3044290) Cell count panel - Cerebral spinal fluid
12
96
1.26
0.24
1.4
1.9
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
16
133
1.21
0.24
4.3
2.4
%
182.4
174.9
0.14
16
128
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
51
466
1.10
0.24
4.5
4.1
%
18.1
21.2
0.95
24
215
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
38
1.32
0.23
1.0
1.1
—
5.3
—
0
10
(44813793)
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.0
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
40
1.25
0.22
1.2
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
127
1329
0.94
0.21
1.6
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
3.1
—
1.2
—
0
10
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(4133840)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
12
0.00
0.21
0.0
2.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
13
0.00
0.21
0.0
1.3
—
8.2
—
0
8
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
13
0.00
0.21
0.0
2.0
—
132339.6
—
0
8
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.0
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
133
0.82
0.19
2.1
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
81
1.24
0.19
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
17
147
1.16
0.18
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
100
1.20
0.18
1.3
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
61
1.15
0.17
1.1
1.3
u/l
16.3
15.1
—
7
55
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
110
1.19
0.17
2.1
1.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
18
158
1.14
0.16
7.1
5.0
%
1.9
1.5
0.55
18
147
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
131
1.15
0.14
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
16
141
1.14
0.14
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
61
580
1.06
0.13
1.9
1.9
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
16
142
1.13
0.12
1.3
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
17
152
1.12
0.12
2.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
16
143
1.12
0.11
1.3
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
320
1.07
0.10
1.5
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
18
164
1.10
0.10
1.1
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
5
46
1.09
0.09
1.6
1.4
—
11.8
—
0
8
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
36
340
1.06
0.09
3.3
2.8
ug/l
0.7
0.7
0.46
26
221
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
47
1.06
0.09
2.4
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
113
0.88
0.08
2.4
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
65
0.77
0.08
1.8
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
11
123
0.89
0.08
2.5
3.5
mg/l
1.4
1.5
0.36
11
113
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
32
304
1.06
0.07
1.8
1.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
83
0.84
0.07
1.3
1.1
—
17.0
—
0
7
(3000330) Specific gravity of Urine by Test strip
23
216
1.07
0.07
2.7
3.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
90
0.89
0.07
4.1
3.2
%
59.4
57.6
—
8
90
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
20
188
1.07
0.05
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
113
1111
1.02
0.05
1.5
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
12
110
1.09
0.05
1.2
1.4
ug/g
193.7
308.5
—
7
61
(3000492) Spirometry study
47
456
1.03
0.05
1.6
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
189
1.06
0.04
3.5
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
12
111
1.08
0.04
1.2
1.9
e6/l
449.8
287.1
0.15
12
85
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
12
111
1.08
0.04
1.2
1.8
e6/l
15.6
7.7
0.29
12
79
(1002224) Polysomnography panel
21
220
0.95
0.03
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
17
178
0.95
0.02
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
17
178
0.95
0.02
1.3
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
288
0.97
0.02
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
17
177
0.96
0.01
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
17
177
0.96
0.01
1.3
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
116
1.04
0.00
1.7
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
15
146
1.03
0.00
4.5
2.1
%
96.2
95.1
0.09
15
138
(4034850)
15
154
0.97
0.00
17.6
7.9
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
73
0.96
0.00
2.9
1.9
%
13.1
13.2
—
7
73
(3022806) Fractional oxyhemoglobin in Capillary blood
5
52
0.96
0.00
1.2
1.7
%
93.1
91.0
—
5
52
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
54
0.93
0.00
1.2
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
62
0.97
0.00
1.0
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
66
0.91
0.00
1.3
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
66
0.91
0.00
1.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
59
0.85
0.00
1.2
1.5
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
57
0.88
0.00
1.4
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
72
0.97
0.00
1.0
1.6
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
1.2
—
74.2
—
0
5
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
67
0.89
0.00
1.3
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
51
0.98
0.00
2.4
1.3
nmol/l
0.8
0.5
—
5
45
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
16.7
—
0
5
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.0
—
0.2
—
0
5
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
89
0.90
0.00
1.1
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
85
0.94
0.00
4.0
2.9
e9/l
4.1
4.5
—
8
85
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_THYROIDITNAS and mortality.

Females

Parameter HR [95% CI] p-value
E4_THYROIDITNAS 1.07 [0.88, 1.3] 0.502
Birth year 0.992 [0.98, 1.0] 0.081

During the follow-up period (1.1.1998 — 31.12.2019), 153 out of 1872 females with E4_THYROIDITNAS died.

Males

Parameter HR [95% CI] p-value
E4_THYROIDITNAS 1.031 [0.79, 1.35] 0.827
Birth year 0.988 [0.98, 1.0] 0.013

During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 435 males with E4_THYROIDITNAS died.

Mortality risk

Mortality risk for people of age

years, who have E4_THYROIDITNAS.

N-year risk Females Males
1 0.1% 0.199%
5 0.55% 1.133%
10 1.31% 2.965%
15 2.674% 5.73%
20 4.741% 9.773%

Relationships between endpoints

↥

Index endpoint: E4_THYROIDITNAS – Thyroiditis, unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data